Abstract CT114: INO-5401 and INO-9012 delivered by electroporation (EP) in combination with cemiplimab (REGN2810) in newly-diagnosed glioblastoma (GBM) (NCT03491683)
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs18-ct114
Abstract: Despite advances in therapy, glioblastoma (GBM) remains one of the most deadly cancers, with five-year survival under 5%. Newer immunotherapies hold promise in the treatment of GBM, and T cell-enabling therapies may improve progression-free and… read more here.
Keywords: ino 9012; ino 5401; cemiplimab; ino ... See more keywords
Abstract CT177: INO-5401 + INO-9012 in combination with atezolizumab for locally advanced unresectable or metastatic/recurrent urothelial carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs18-ct177
Abstract: Background: Advanced urothelial carcinoma (UCa; bladder cancer) remains a deadly disease with patients often failing to respond to, or ineligible for, platinum-based therapy. Checkpoint inhibitors (CPIs) have increased response rates, but a majority of patients… read more here.
Keywords: ino 9012; locally advanced; 5401 ino; advanced unresectable ... See more keywords